Back
United Therapeutics Stock Predictions
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
UTHR
United Therapeutics
Last Price:
$280.70
Seasonality Move:
4.96%
7 Day Trial
ALL ACCESS PASS
$
7
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.United Therapeutics Stock Forecast
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.9% based on the past 25 years of stock performance.
-
United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
-
Is United Therapeutics Stock Undervalued?The current United Therapeutics [UTHR] share price is $278.89. The Score for UTHR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics has on average historically risen by 18.9% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Sell
41
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics overpriced?
-
United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
417.82
52-Week Low:
230.39
Prediction Charts
Market Cap:
12.5B
Price in USD:
278.89
Volume:
595.8K
Beta:
0.53
Technical Analysis
SMA50:
328.30
SMA100:
347.78
SMA200:
346.17
52-Wk Change:
17.28%
Stock Predictions
-
Is United Therapeutics stock public?Yes, United Therapeutics is a publicly traded company.
-
What is the United Therapeutics stock quote today?The United Therapeutics stock price is 278.89 USD today.
-
How to buy United Therapeutics stock online?You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-24 | 313.18 | 319.86 | 320.67 | 313.18 |
| Mar-25 | 322.32 | 316.73 | 322.32 | 312.38 |
| Mar-26 | 313.72 | 310.82 | 315.42 | 309.99 |
| Mar-27 | 311.87 | 308.02 | 318.40 | 307.57 |
| Mar-28 | 309.58 | 306.97 | 309.58 | 304.03 |
| Mar-31 | 303.77 | 308.27 | 309.64 | 298.60 |
| Apr-1 | 308.17 | 306.88 | 311.55 | 303.33 |
| Apr-2 | 303.78 | 312.26 | 313.41 | 303.16 |
| Apr-3 | 300.00 | 307.36 | 312.14 | 298.00 |
| Apr-4 | 302.83 | 292.46 | 308.10 | 290.33 |
| Apr-7 | 284.55 | 291.72 | 299.07 | 273.12 |
| Apr-8 | 299.08 | 279.69 | 304.81 | 275.94 |
| Apr-9 | 275.55 | 292.78 | 294.63 | 266.98 |
| Apr-10 | 285.88 | 278.89 | 287.44 | 269.93 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.40 per share, and an increase next year of $0.56 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.